- Home
- BCAL vs SGP Comparison
BCAL vs SGP Comparison
Compare BCAL & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCAL | SGP |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.9M | 650.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCAL | SGP |
|---|---|---|
| Price | $19.65 | $19.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $20.67 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 160.2K | 64.0K |
| Earning Date | 04-28-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 777.27 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.67 | N/A |
| P/E Ratio | $47.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.57 | $17.06 |
| 52 Week High | $20.47 | $30.56 |
Technical Indicators
Market Signals| Indicator | BCAL | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 58.43 | 49.37 |
| Support Level | $18.49 | $17.60 |
| Resistance Level | $19.95 | $20.25 |
| Average True Range (ATR) | 0.41 | 1.13 |
| MACD | 0.01 | 0.23 |
| Stochastic Oscillator | 75.74 | 83.70 |
Price Performance
Historical ComparisonAbout BCAL Southern California Bancorp
California BanCorp is a relationship-focused community bank offering commercial loan and deposit products, along with other services delivered directly or through strategic alliances, to business and individual customers in its target markets. The Company provides financial products and services to individuals, professionals, and small to medium-sized businesses through its branch and commercial banking offices serving California. Its lending products consist mainly of construction and land development loans, real estate loans, C&I loans, and consumer loans, and it is a Preferred SBA Lender, while its deposit products consist mainly of demand deposit, money market, and certificates of deposit. The Company operates in one reportable segment, commercial banking.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.